Clinical Trial Update: A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 1 study to determine a suitable dose of ASP5834 in adults with solid tumors, including non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Solid Tumor

Drugs mentioned

• ASP5834 (ASP5834)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Solid Tumor, Non-Small-Cell Lung Cancer | Phase 1 | Status: RECRUITING